{"id":"https://openalex.org/W1997458334","doi":"https://doi.org/10.1023/a:1024778329320","title":"A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development","display_name":"A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development","publication_year":2003,"publication_date":"2003-06-01","ids":{"openalex":"https://openalex.org/W1997458334","doi":"https://doi.org/10.1023/a:1024778329320","mag":"1997458334","pmid":"https://pubmed.ncbi.nlm.nih.gov/12945744"},"language":"en","primary_location":{"id":"doi:10.1023/a:1024778329320","doi":"https://doi.org/10.1023/a:1024778329320","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1024778329320","pdf_url":null,"source":{"id":"https://openalex.org/S31257671","display_name":"Cell Biology and Toxicology","issn_l":"0742-2091","issn":["0742-2091","1573-6822"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Biology and Toxicology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006927938","display_name":"Alessandro Casartelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"A. Casartelli","raw_affiliation_strings":["Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy. AC48574@gsk.com","Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy. AC48574@gsk.com","institution_ids":["https://openalex.org/I4210128413"]},{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033729887","display_name":"Monica Bonato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M. Bonato","raw_affiliation_strings":["Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009654306","display_name":"Patrizia G. Cristofori","orcid":"https://orcid.org/0000-0002-3867-062X","observed_orcids":["https://orcid.org/0000-0002-3867-062X"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P. Cristofori","raw_affiliation_strings":["Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068727659","display_name":"Federica Crivellente","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F. Crivellente","raw_affiliation_strings":["Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058562874","display_name":"Giulia Negro","orcid":"https://orcid.org/0000-0002-4000-786X","observed_orcids":["https://orcid.org/0000-0002-4000-786X"]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G. Dal Negro","raw_affiliation_strings":["Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090422704","display_name":"I. Masotto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"I. Masotto","raw_affiliation_strings":["Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076093135","display_name":"Chiara Mutinelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I119439378","display_name":"University of Verona","ror":"https://ror.org/039bp8j42","country_code":"IT","type":"education","lineage":["https://openalex.org/I119439378"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C. Mutinelli","raw_affiliation_strings":["Facolt\u00e1 di Medicina e Chirurgia, University of Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facolt\u00e1 di Medicina e Chirurgia, University of Verona, Italy","institution_ids":["https://openalex.org/I119439378"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029179936","display_name":"Klara Livia Valko","orcid":"https://orcid.org/0000-0003-4605-2941","observed_orcids":["https://orcid.org/0000-0003-4605-2941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Valko","raw_affiliation_strings":["Analytical Sciences Stevenage Department, Glaxo Medicines R&D Centre, Stevenage, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Analytical Sciences Stevenage Department, Glaxo Medicines R&D Centre, Stevenage, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"V. Bonfante","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128413","display_name":"GlaxoSmithKline (Italy)","ror":"https://ror.org/03fe56089","country_code":"IT","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210128413"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"V. Bonfante","raw_affiliation_strings":["Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Safety Assessment Department, GlaxoSmithKline Research Centre, Verona, Italy","institution_ids":["https://openalex.org/I4210128413"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":2.3241,"has_fulltext":false,"cited_by_count":81,"citation_normalized_percentile":{"value":0.86691755,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"19","issue":"3","first_page":"161","last_page":"176"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.11240000277757645,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.11240000277757645,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10407","display_name":"Lipid Membrane Structure and Behavior","score":0.08449999988079071,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.0820000022649765,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phospholipidosis","display_name":"phospholipidosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/cationic-amphiphilic-drugs","display_name":"cationic amphiphilic drugs","score":0.9980000257492065},{"id":"https://openalex.org/keywords/u937-cells","display_name":"U937 cells","score":0.953000009059906},{"id":"https://openalex.org/keywords/nile-red","display_name":"Nile Red","score":0.5820000171661377},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.6650000214576721},{"id":"https://openalex.org/keywords/monocyte-derived-cells","display_name":"monocyte-derived cells","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2779934242","wikidata":"https://www.wikidata.org/wiki/Q7187520","display_name":"Phospholipidosis","level":4,"score":0.9973413348197937},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.6930357217788696},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.5568436980247498},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5531441569328308},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5071156024932861},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4785645306110382},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4737839698791504},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.45701438188552856},{"id":"https://openalex.org/C115448650","wikidata":"https://www.wikidata.org/wiki/Q409205","display_name":"Xenobiotic","level":3,"score":0.440535306930542},{"id":"https://openalex.org/C157044486","wikidata":"https://www.wikidata.org/wiki/Q5754482","display_name":"High-content screening","level":3,"score":0.4278465211391449},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.41813924908638},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.39335429668426514},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3813649117946625},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36390626430511475},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3545057475566864},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.2330116331577301},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.08218169212341309},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002412","descriptor_name":"Cations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008064","descriptor_name":"Lipidoses","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013194","descriptor_name":"Staining and Labeling","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D013501","descriptor_name":"Surface-Active Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D015262","descriptor_name":"Xenobiotics","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D015262","descriptor_name":"Xenobiotics","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D020127","descriptor_name":"Recovery of Function","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020298","descriptor_name":"U937 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020298","descriptor_name":"U937 Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1023/a:1024778329320","doi":"https://doi.org/10.1023/a:1024778329320","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1024778329320","pdf_url":null,"source":{"id":"https://openalex.org/S31257671","display_name":"Cell Biology and Toxicology","issn_l":"0742-2091","issn":["0742-2091","1573-6822"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Biology and Toxicology","raw_type":"journal-article"},{"id":"pmid:12945744","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12945744","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell biology and toxicology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1514511377","https://openalex.org/W1518557248","https://openalex.org/W1966009072","https://openalex.org/W1973089220","https://openalex.org/W1975877182","https://openalex.org/W1978629640","https://openalex.org/W1979094327","https://openalex.org/W1979233147","https://openalex.org/W1986631454","https://openalex.org/W1997392516","https://openalex.org/W1998820852","https://openalex.org/W2005209160","https://openalex.org/W2010321956","https://openalex.org/W2015032724","https://openalex.org/W2017424821","https://openalex.org/W2039289294","https://openalex.org/W2047021606","https://openalex.org/W2055718969","https://openalex.org/W2057125222","https://openalex.org/W2061192110","https://openalex.org/W2073976519","https://openalex.org/W2079541326","https://openalex.org/W2083122813","https://openalex.org/W2088275367","https://openalex.org/W2090137426","https://openalex.org/W2122734844","https://openalex.org/W2133764756","https://openalex.org/W2134579258","https://openalex.org/W2140986765","https://openalex.org/W2141163306","https://openalex.org/W2147865715","https://openalex.org/W2148486676","https://openalex.org/W2151304558","https://openalex.org/W2154716132","https://openalex.org/W2156160866","https://openalex.org/W2300061990","https://openalex.org/W2303080388","https://openalex.org/W2333804316","https://openalex.org/W2394856876","https://openalex.org/W2409112218","https://openalex.org/W2417530412"],"related_works":["https://openalex.org/W2117647430","https://openalex.org/W4225457874","https://openalex.org/W2076911132","https://openalex.org/W1997278096","https://openalex.org/W2593219363","https://openalex.org/W1986702471","https://openalex.org/W2036098599","https://openalex.org/W1968037013","https://openalex.org/W2088827589","https://openalex.org/W2069129703"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}